Database : HANSEN Search on : ISONIAZIDA/USO TERAP [Subject descriptor] References found : 7 [refine] Displaying: 1 .. 7   in format [Detailed]

page 1 de 1

1 / 7

HANSEN

select to print

Id: 13518 Author: Freerksen, Enno; Rosenfeld, Magdalena Title: Leprosy eradication project of Malta. First published report after 5 years running ..- Source: s.l; s.n; 1977. 31 p. ilus, mapas, tab. Abstract: This is first publication of the initial 5-year-period of the eradication programme since its introduction in ther Maltese....(AU). Descriptors: TECNICAS BACTERIOLOGICAS DAPSONA/uso terap ISONIAZIDA/uso terap QUIMIOTERAPIA COMBINADA HANSENIASE/quimioter HANSENIASE/prev MALTA PROTIONAMIDA/uso terap RIFAMPINA/uso terap FATORES DE TEMPO Limits: RELATO DE CASO HUMANO MASCULINO FEMININO CRIANÇA ADULTO MEIA-IDADE IDOSO ADOLESCENTE Electronic Medium: http://www.ilsl.br Location: BR191.1; 00602/s

2 / 7

HANSEN

select to print

Id: 13445 Author: Pilheu, J. A; De Salvo, Maria de C; Barcat, J. A Title: Acción de los esquemas con isoniacida y rifampicina sobre el hígado de enfermos tuberculosos Effect of isoniazid and rifampicin regimens on the liver of tuberculosis patients- Source: s.l; s.n; May-Jun. 1979. 7 p. tab. Abstract: Se estudió un grupo de 86 enfermos tuberculosos que recebieron esquemas terapèuticos con Isoniacida y Rifampicina y se evaluó la acción de esas drogas sobre el hígado. Para ello, antes de iniciar la quimioterapia, se praticó una biopsia hepática y se dosaron transaminasas, fosfatasa y bilirrubina séricas; al finalizar el tercer mes de tratamiento se repitió una biopsia hepática. Los tests funcionales se repitieron mensualmente durante todo el tratamiento. El grupo I (10 casos) recibió Isonacida, Ethambutol y Estreptomicina. En la biopsia inicial hubo 1 caso con transformación grasa y 1 con necrosis focal; al 3er. mes persistía la necrosis focal en 1 caso y apreció en otros 3. El grupo II (14 casos) recibió Rifampicina, Ethambutol y Capreomicina.(AU). Descriptors: QUIMIOTERAPIA COMBINADA ETAMBUTOL/uso terap ISONIAZIDA/admin ISONIAZIDA/farmacol ISONIAZIDA/uso terap RIFAMPINA/admin RIFAMPINA/farmacol RIFAMPINA/uso terap FIGADO/patol Limits: HUMANO MASCULINO FEMININO ADULTO MEIA-IDADE IDOSO ADOLESCENTE RESUMO EM INGLES Electronic Medium: http://www.ilsl.br Location: BR191.1; 00140/s

3 / 7

HANSEN

select to print

Id: 13299 Author: Kundu, S. K; Ghosh, S; Hazra, S; Chaudhury, S Title: Multiple drug therapy--a comparative study with 2 tier and 3 tier combination of rifampicin, clofazimine, DDS, INAH and thiacetazone in lepromatous cases ..- Source: s.l; s.n; apr. 1981. 11 p. tab. Abstract: A comparative study with 2 tier and 3 tier combination of Rifampicin, Clofazimine, DDS, INAH and Thiacetazone was conducted on fifty lepromatous leprosy cases for varying periods. Assessment showed that 2 tier combination of clofazimine and DDS produced good results but the cost stood in the way; whereas 3 tier combination of DDS, thiacetazone and INAH also yielded good results with much less expenses to be incurred by the patients. Whether therapy with this 3 tier combination could be continued for a longer period with sustained improvement is yet to be assessed by further studies for a considerable period.(AU). Descriptors: HANSENIASE/quimioter ISONIAZIDA/uso terap RIFAMPINA/uso terap TIOACETAZONA/uso terap DAPSONA/uso terap QUIMIOTERAPIA COMBINADA CLOFAZIMINA/uso terap Limits: ESTUDO COMPARATIVO HUMANO MASCULINO FEMININO CRIANÇA ADULTO MEIA-IDADE ADOLESCENTE Electronic Medium: http://www.ilsl.br Location: BR191.1; 00695

4 / 7

HANSEN

select to print

Id: 13295 Author: Freerksen, Enno; Rosenfeld, Magdalena; Bonnici, Edgar; Depasquale, George; Kriiger-Thiemer, Malwine Title: Combined therapy in leprosy. Background and findings ..- Source: s.l; s.n; 1978. 5 p. tab. Abstract: This report is based on data obtained from 64 lepromatous cases. Despite many years of DDS monotherapy, the homogenates from biopsies of these patients revealed 10(4) or more bacteria. From the beginning of combination therapy with synergistic-acting substances (rifampicin + isoprodian (INH + PTH + DDS) the logarithms of the number of bacteria in the homogenates decreased, both during treatment period and during treatment-free observation period (Figs. 3--8). During the whole time biopsies were taken almost monthly. A considerable regression of the bacterial mass or even negativity could be observed within a relatively short time. Once started, the process of reduction of bacteria continued also after termination of therapy. To be able to evaluate a medication, therapy-free observation periods (for a minimum of 5 years) are indispensable.(AU). Descriptors: COMBINACAO DE MEDICAMENTOS QUIMIOTERAPIA COMBINADA ISONIAZIDA/uso terap HANSENOSTATICOS/uso terap HANSENIASE/clas HANSENIASE/quimioter HANSENIASE/imunol PROTIONAMIDA/uso terap DAPSONA/uso terap RIFAMPINA/uso terap Limits: HUMANO Electronic Medium: http://www.ilsl.br Location: BR191.1; 00599/s

5 / 7

HANSEN

select to print

Id: 12280 Author: Freerksen, Enno; Rosenfeld, Magdalena; Depasquale, George; Bonnici, Edgar; Gatt, Paul Title: The Malta Project - A country freed itself of leprosy: a 27-year progress study (1972-1999) of the first successful eradication of leprosy ..- Source: s.l; s.n; 2001. 23 p. tab, graf. Descriptors: TERAPIA COMBINADA DAPSONA ISONIAZIDA LEPROSTATICOS HANSENIASE HANSENIASE MALTA AVALIAÇAO DE PROGRAMAS PROTIONAMIDA SAUDE PUBLICA RIFAMPINA RESULTADO DE TRATAMENTO Location: BR191.1; 08632/s

6 / 7

HANSEN

select to print

Id: 11492 Author: Freerksen, Enno; Rosenfeld, Magdalena; Depasquale, George; Bonnici, Edgar; Gatt, Paul Title: The Malta Project - a country freed itself of leprosy ..- Source: s.l; s.n; 2001. 23 p. ilus, tab, graf. Descriptors: HANSENIASE HANSENIASE TERAPIA COMBINADA DAPSONA ISONIAZIDA LEPROSTATICOS MALTA PROTIONAMIDA RIFAMPINA RESULTADO DE TRATAMENTO Location: BR191.1; 08362/s

7 / 7

HANSEN

select to print

Id: 9418 Author: Freerkesen, E; Seydel, J. K Title: Critical comments on the treatment of leprosy and other mycobacterial infections with clofazimine ..- Source: s.l; s.n; 1992. 3 p. tab. Descriptors: QUIMIOTERAPIA COMBINADA ERITEMA NODOSO ISONIAZIDA ISONIAZIDA LEPROSTATICOS HANSENIASE DIMORFA HANSENIASE LEPROMATOSA RECIDIVA RIFAMPINA RIFAMPINA FATORES DE TEMPO COMBINAÇAO TRIMETOPRIM-SULFAMETOXAZOL Location: BR191.1; 06384/s

---

page 1 de 1

Refine the search

Database : HANSEN

Advanced form

Search for : Free form

		Search	in field
1			WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type
2	and or and not		WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type
3	and or and not		WordsTitle wordsAbstract wordsAuthorInstitutional authorSubject descriptorLimitsLanguageCountry, year publicationJournalType of literatureBibliographic levelMonography in seriesPublication typeConferenceUnique identifierLocationElectronic supportEntry dateRecord type

Search engine: iAH powered by WWWISIS

IAH - © BIREME/PAHO/WHO Latin American and Caribbean Center on Health Sciences Information